- Home
- Publications
- Publication Search
- Publication Details
Title
Measles to the Rescue: A Review of Oncolytic Measles Virus
Authors
Keywords
-
Journal
Viruses-Basel
Volume 8, Issue 10, Pages 294
Publisher
MDPI AG
Online
2016-10-24
DOI
10.3390/v8100294
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells
- (2016) Mutsumi Awano et al. CANCER SCIENCE
- The Immunomodulatory Potential of Mesenchymal Stromal Cells
- (2016) Mehdi Najar et al. JOURNAL OF IMMUNOTHERAPY
- The Role of Neutrophils in Measles Virus–mediated Oncolysis Differs Between B-cell Malignancies and Is Not Always Enhanced by GCSF
- (2016) Aditi Dey et al. MOLECULAR THERAPY
- A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells
- (2015) Tomoko Fujiyuki et al. Oncotarget
- Characterization of Magnetic Viral Complexes for Targeted Delivery in Oncology
- (2015) Isabella Almstätter et al. Theranostics
- MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
- (2014) M A Baertsch et al. CANCER GENE THERAPY
- Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer
- (2014) E. Galanis et al. CANCER RESEARCH
- Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy
- (2014) Stephen J. Russell et al. MAYO CLINIC PROCEEDINGS
- CTLA-4 and PD-L1 Checkpoint Blockade Enhances Oncolytic Measles Virus Therapy
- (2014) Christine E Engeland et al. MOLECULAR THERAPY
- Pulsed Versus Continuous Application of the Prodrug 5-Fluorocytosine to Enhance the Oncolytic Effectiveness of a Measles Vaccine Virus Armed with a Suicide Gene
- (2014) Can Yurttas et al. Human Gene Therapy Clinical Development
- Human mesenchymal stromal cells deliver systemic oncolytic measles virus to treat acute lymphoblastic leukemia in the presence of humoral immunity
- (2013) A. Castleton et al. BLOOD
- Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer
- (2013) S A Quezada et al. BRITISH JOURNAL OF CANCER
- Specific Elimination of CD133+ Tumor Cells with Targeted Oncolytic Measles Virus
- (2013) P. Bach et al. CANCER RESEARCH
- Measles Virus Vaccine-Infected Tumor Cells Induce Tumor Antigen Cross-Presentation by Human Plasmacytoid Dendritic Cells
- (2013) J.-B. Guillerme et al. CLINICAL CANCER RESEARCH
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis
- (2013) J Lampe et al. GENE THERAPY
- Enhanced killing of ovarian carcinoma using oncolytic measles vaccine virus armed with a yeast cytosine deaminase and uracil phosphoribosyltransferase
- (2013) A.D. Hartkopf et al. GYNECOLOGIC ONCOLOGY
- Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer
- (2013) Yu-Ping Liu et al. GYNECOLOGIC ONCOLOGY
- Granulocyte-Macrophage Colony-Stimulating Factor-Armed Oncolytic Measles Virus Is an Effective Therapeutic Cancer Vaccine
- (2013) Christian Grossardt et al. HUMAN GENE THERAPY
- A Novel Armed Oncolytic Measles Vaccine Virus for the Treatment of Cholangiocarcinoma
- (2013) Sebastian Lange et al. HUMAN GENE THERAPY
- Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth
- (2013) Hooi-Tin Ong et al. JOURNAL OF HEPATOLOGY
- Innate Immune Defense Defines Susceptibility of Sarcoma Cells to Measles Vaccine Virus-Based Oncolysis
- (2013) S. Berchtold et al. JOURNAL OF VIROLOGY
- DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety
- (2013) Katrin Friedrich et al. MOLECULAR THERAPY
- Measles Virus Entry Through the Signaling Lymphocyte Activation Molecule Governs Efficacy of Mantle Cell Lymphoma Radiovirotherapy
- (2013) Tanner S Miest et al. MOLECULAR THERAPY
- Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition
- (2013) Yann Touchefeu et al. RADIOTHERAPY AND ONCOLOGY
- Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodine
- (2012) Brian Hutzen et al. BMC CANCER
- Oncolytic measles virus strains have significant antitumor activity against glioma stem cells
- (2012) C Allen et al. GENE THERAPY
- Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses
- (2012) K-W Peng et al. GENE THERAPY
- Chemovirotherapy of Malignant Melanoma with a Targeted and Armed Oncolytic Measles Virus
- (2012) Johanna K. Kaufmann et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus
- (2012) Ianko D Iankov et al. MOLECULAR THERAPY
- Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus
- (2011) Y-P Liu et al. CANCER GENE THERAPY
- Armed and targeted measles virus for chemovirotherapy of pancreatic cancer
- (2011) S Bossow et al. CANCER GENE THERAPY
- Measles virus causes immunogenic cell death in human melanoma
- (2011) O G Donnelly et al. GENE THERAPY
- Oncolytic Measles Virus Encoding Thyroidal Sodium Iodide Symporter for Squamous Cell Cancer of the Head and Neck Radiovirotherapy
- (2011) Hongtao Li et al. HUMAN GENE THERAPY
- Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis
- (2011) Tanner S Miest et al. MOLECULAR THERAPY
- Differential Cytopathology and Kinetics of Measles Oncolysis in Two Primary B-cell Malignancies Provides Mechanistic Insights
- (2011) Bella Patel et al. MOLECULAR THERAPY
- MicroRNA-sensitive Oncolytic Measles Viruses for Cancer-specific Vector Tropism
- (2011) Mathias F Leber et al. MOLECULAR THERAPY
- Adherens junction protein nectin-4 is the epithelial receptor for measles virus
- (2011) Michael D. Mühlebach et al. NATURE
- The heads of the measles virus attachment protein move to transmit the fusion-triggering signal
- (2011) Chanakha K Navaratnarajah et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Targeted Cell Fusion Facilitates Stable Heterokaryon Generation In Vitro and In Vivo
- (2011) Michael A. Long et al. PLoS One
- Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
- (2011) Antonella Sistigu et al. Seminars in Immunopathology
- Tumor Cell Marker PVRL4 (Nectin 4) Is an Epithelial Cell Receptor for Measles Virus
- (2011) Ryan S. Noyce et al. PLoS Pathogens
- Nectin 4 Overexpression in Ovarian Cancer Tissues and Serum
- (2010) Melissa S. DeRycke et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Sodium Iodide Symporter (NIS)-Mediated Radiovirotherapy for Pancreatic Cancer
- (2010) Alan R. Penheiter et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Oncolytic measles viruses encoding interferon β and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy
- (2010) H Li et al. CANCER GENE THERAPY
- Liver Cancer Protease Activity Profiles Support Therapeutic Options with Matrix Metalloproteinase-Activatable Oncolytic Measles Virus
- (2010) M. D. Muhlebach et al. CANCER RESEARCH
- Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer
- (2010) E. Galanis et al. CANCER RESEARCH
- Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics
- (2010) G Ungerechts et al. GENE THERAPY
- Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell Carriers
- (2010) Chunsheng Liu et al. MOLECULAR THERAPY
- Identification of Nectin-4 Oncoprotein as a Diagnostic and Therapeutic Target for Lung Cancer
- (2009) A. Takano et al. CANCER RESEARCH
- Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy Model
- (2009) E. K. Mader et al. CLINICAL CANCER RESEARCH
- Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways
- (2009) Shruthi Naik et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter
- (2009) Pavlos Msaouel et al. MOLECULAR THERAPY
- Converting Tumor-specific Markers Into Reporters of Oncolytic Virus Infection
- (2009) Ianko D Iankov et al. MOLECULAR THERAPY
- Intravascularly Administered RGD-Displaying Measles Viruses Bind to and Infect Neovessel Endothelial Cells In Vivo
- (2009) Hooi Tin Ong et al. MOLECULAR THERAPY
- Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer
- (2009) Chunsheng Liu et al. PROSTATE
- Interferon regulatory factor family of transcription factors and regulation of oncogenesis
- (2008) Akinori Takaoka et al. CANCER SCIENCE
- Heat shock protein inhibitors increase the efficacy of measles virotherapy
- (2008) C Liu et al. GENE THERAPY
- Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed
- (2008) Vincent H.J. Leonard et al. JOURNAL OF CLINICAL INVESTIGATION
- Interleukin-13 Displaying Retargeted Oncolytic Measles Virus Strains Have Significant Activity Against Gliomas With Improved Specificity
- (2008) Cory Allen et al. MOLECULAR THERAPY
- Engineered measles virus as a novel oncolytic therapy against prostate cancer
- (2008) Pavlos Msaouel et al. PROSTATE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now